Identification of tocopherol-associated protein as an activin/TGF-beta-inducible gene in mast cells

Biochim Biophys Acta. 2006 Aug;1763(8):900-6. doi: 10.1016/j.bbamcr.2006.06.002. Epub 2006 Jun 17.

Abstract

Previous studies have demonstrated that treatment with activin A and TGF-beta(1), members of the TGF-beta family, stimulated maturation of mouse bone marrow-derived cultured mast cells (BMMC), which was characterized by morphology and gene expression of mouse mast cell proteases (mmcps). In order to gain a better understanding of activin A- and TGF-beta(1)-induced maturation in mast cells, we investigated the genes that were up-regulated in response to treatment with these two members of the TGF-beta family. The cDNA microarray analyses indicated that in BMMC, five genes were induced by treatment with 4 nM activin A for 2 h. Tocopherol-associated protein (Tap) was one of the induced genes, and the Tap induction in response to activin A treatment was confirmed by real-time RT-PCR analyses. Treatment with TGF-beta(1) at 200 pM but not BMP-2 at 4 nM also increased Tap gene transcript in BMMC. Activin A-induced Tap expression was detected in BMMC but not in RAW264 macrophage-like cells, B16 melanoma cells or P19 embryonic carcinoma cells. Treatment with >1 muM SB431542, an inhibitor of activin and TGF-beta type I receptors ALK4/5, reduced responsiveness of Tap expression to TGF-beta(1), whereas <0.5 microM SB431542 effectively reduced TGF-beta(1)-induced expression of mmcp-1 and mmcp-7. These results suggest that inhibitory effects of SB431542 are different between TGF-beta-induced genes. Reporter assays indicated that Tap expression enhances transcription mediated by the activin/TGF-beta pathway. Thus, the present results suggest that Tap induction in response to activin/TGF-beta occurs predominantly in mast cells and serves as a positive regulator in activin/TGF-beta signaling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activin Receptors, Type I / antagonists & inhibitors
  • Activins / antagonists & inhibitors
  • Activins / pharmacology*
  • Animals
  • Benzamides / pharmacology
  • Carrier Proteins / genetics*
  • Cell Line
  • Cells, Cultured
  • DNA, Complementary / genetics
  • Dioxoles / pharmacology
  • Gene Expression Regulation / drug effects
  • Inhibin-beta Subunits / antagonists & inhibitors
  • Inhibin-beta Subunits / pharmacology*
  • Lipoproteins / genetics*
  • MAP Kinase Signaling System
  • Mast Cells / drug effects*
  • Mast Cells / metabolism*
  • Mice
  • Oligonucleotide Array Sequence Analysis
  • Receptors, Transforming Growth Factor beta / antagonists & inhibitors
  • Signal Transduction
  • Smad3 Protein / deficiency
  • Smad3 Protein / genetics
  • Trans-Activators / genetics*
  • Transforming Growth Factor beta / antagonists & inhibitors
  • Transforming Growth Factor beta / pharmacology*
  • Transforming Growth Factor beta1

Substances

  • 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide
  • Benzamides
  • Carrier Proteins
  • DNA, Complementary
  • Dioxoles
  • Lipoproteins
  • Receptors, Transforming Growth Factor beta
  • Smad3 Protein
  • Smad3 protein, mouse
  • Tgfb1 protein, mouse
  • Trans-Activators
  • Transforming Growth Factor beta
  • Transforming Growth Factor beta1
  • activin A
  • tocopherol-associated protein, mouse
  • Activins
  • Inhibin-beta Subunits
  • Activin Receptors, Type I